Lab
Laboratorio Clinico Jollymar INC
Laboratorio Clinico Jollymar INC was paid $2.26M by Medicaid between Jan 2018 and Dec 2024, across 64 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 14% of everything it billed.
33Billing provider infoLABORATORIO CLINICO JOLLYMAR INC
TOA ALTA, PR 00953
TOA ALTA, PR 00953
33aNPI1194711648assigned 09/21/2005
33bProvider typeClinical Medical Laboratory
28Total paid$2.26M
24GClaims162,703
24DCodes billed64
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#42 of 777
Median peer was paid$278K
This provider vs. median8.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,604 | $119K | |
| 2019 | 14,115 | $130K | |
| 2020 | 21,916 | $330K | |
| 2021 | 33,023 | $585K | |
| 2022 | 27,261 | $438K | |
| 2023 | 25,897 | $301K | |
| 2024incomplete | 27,887 | $356K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 14% | 7,722 | 6,579 | $312K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 11% | 10,808 | 9,312 | $258K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.8% | 4,002 | 3,670 | $200K |
| 84443 | Thyroid stimulating hormone (TSH) | 8.4% | 12,501 | 11,196 | $190K |
| 80061 | Lipid panel | 7.1% | 12,637 | 11,285 | $160K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.2% | 5,064 | 4,510 | $139K |
| 80053 | Comprehensive metabolic panel | 6.1% | 14,288 | 12,687 | $137K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.9% | 15,618 | 13,503 | $112K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.7% | 6,556 | 5,832 | $60K |
| 86328 | 2.6% | 2,826 | 2,671 | $60K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.3% | 1,532 | 1,340 | $53K |
| 82274 | 2.3% | 3,469 | 3,107 | $52K |
52 more codes
| 81000 | 2.1% | 16,019 | $48K | |
| 86701 | 1.9% | 4,783 | $42K | |
| 86738 | 1.6% | 2,696 | $35K | |
| 87276 | 1.3% | 2,500 | $30K | |
| 84153 | 1.3% | 1,691 | $29K | |
| 85027 | 1.3% | 5,060 | $29K | |
| 80074 | 1.2% | 582 | $28K | |
| 87275 | 1.2% | 2,336 | $27K | |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 3,102 | $25K |
| 82607 | 1.0% | 1,651 | $23K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,771 | $21K |
| 87590 | <1% | 952 | $19K | |
| 86803 | <1% | 1,433 | $19K | |
| 84439 | <1% | 2,042 | $18K | |
| 82043 | <1% | 3,049 | $17K | |
| 86780 | <1% | 1,214 | $15K | |
| 87088 | <1% | 1,857 | $14K | |
| 87400 | <1% | 890 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,239 | $10K |
| 84436 | <1% | 1,354 | $9K | |
| 87177 | <1% | 1,020 | $7K | |
| 84479 | <1% | 1,080 | $7K | |
| 86592 | <1% | 1,450 | $6K | |
| 80050 | General health panel | <1% | 612 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 113 | $5K |
| 85651 | <1% | 1,165 | $4K | |
| 86038 | <1% | 256 | $3K | |
| 82570 | <1% | 527 | $3K | |
| 83970 | <1% | 82 | $3K | |
| 86140 | <1% | 481 | $2K | |
| 85730 | <1% | 294 | $2K | |
| 85610 | <1% | 378 | $1K | |
| 83655 | <1% | 116 | $1K | |
| 86696 | <1% | 61 | $1K | |
| 87899 | <1% | 58 | $1K | |
| 86695 | <1% | 73 | $969.51 | |
| 83540 | <1% | 95 | $623.08 | |
| 86431 | <1% | 110 | $584.55 | |
| 82950 | <1% | 118 | $565.19 | |
| 82728 | <1% | 32 | $423.77 | |
| 83525 | <1% | 39 | $405.71 | |
| 82951 | <1% | 28 | $348.04 | |
| 82378 | <1% | 23 | $276.48 | |
| 86790 | <1% | 19 | $259.19 | |
| 83001 | <1% | 14 | $257.81 | |
| 81003 | <1% | 57 | $246.69 | |
| 84550 | <1% | 65 | $246.52 | |
| 82952 | <1% | 29 | $182.04 | |
| 86787 | <1% | 12 | $130.06 | |
| 83550 | <1% | 13 | $106.00 | |
| 80069 | <1% | 12 | $97.74 | |
| 82947 | <1% | 27 | $94.88 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialORTIZ, JOLLY (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Laboratorio Clinico Aquarium INC | Toa Alta, PR | $1.32M |
| Laboratorio Clinico Martin INC | Bayamon, PR | $1.10M |
| Laboratorio Clinico Victoria INC | Bayamon, PR | $628K |
| Laboratorio Clinico Jollymar INC | Dorado, PR | $382K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.